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Abstract Nicotine-induced ATP secretion from chromaffin 
cells was blocked by imipramine and desipramine. This blocking 
action took place on both, fast and slow, components of ATP 
secretion. Exposure of chromaffin cells to nicotine (10 uM) for 
4 s induced an inward current of about 155 pA. Imipramine and 
desipramine blocked, in a concentration-dependent manner, both 
peak inward current and total charge influx in response to 
nicotine. In addition, imipramine and desipramine partially 
(40%) blocked depolarization-induced ATP secretion and Ca2 + 
currents evoked by high K+ . This suggests that tricyclic 
antidepressants block nicotine-induced ATP secretion by acting 
on two targets: one is the nicotinic receptor itself and the second 
one are voltage-dependent Ca2 + channels. 
© 1997 Federation of European Biochemical Societies. 
Key words: Nicotine; A T P secretion; Chromaffin cell; 
Imipramine; Desipramine; Calcium channel 
1. Introduction 
Tricyclic antidepressant drugs have been widely used to 
block catecholamine uptake-1 transport system (for review 
see [1]). However, in addition to this pharmacological prop-
erty, these drugs also produce blockade of cholinergic muscar-
inic [2] and nicotinic [3] receptors and a-adrenoceptors [4]. 
Pharmacological actions on these sites may be responsible 
for the known side-effects of tricyclic antidepressant drugs. 
Chromaffin cells secrete catecholamines (CA) and A T P in 
response to different stimuli (for review see [5]). Under phys-
iological conditions, acetylcholine is released from splanchnic 
nerve terminals and interacts with nicotinic receptors produc-
ing depolarization of chromaffin cell membrane [6,7]. This 
depolarization opens voltage-dependent Ca 2 + channels [8,9], 
which produce an increase in intracellular Ca 2 + levels ([Ca2+]i) 
[10] and CA and A T P secretion [11]. 
In addition to cholinergic agonists, neuronal nicotinic re-
ceptors located in bovine chromaffin cells are also targets for a 
variety of drugs and toxins, like L-type voltage-dependent 
Ca 2 + channel blockers [12], co-conotoxin GVIA, a toxin 
from the snail Conus geographus which is a selective blocker 
of N-type voltage-dependent Ca 2 + channels [13], co-agatoxin 
IVA, a specific blocker of P-type voltage-dependent Ca 2 + 
channels obtained from the spider Agelenopsis aperta [14] 
and the diuretic cyclothiazide [15] whose interaction with the 
nicotinic receptor blocks its function. In a previous work, it 
was showed that, when imipramine was used as uptake-1 
transport system blocker in chromaffin cells to enhance CA 
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secretion in response to nicotine, CA secretion was markedly 
decreased in a dose-dependent fashion [16]. 
To identify the target for the observed blocking actions of 
tricyclic antidepressants on secretion from chromaffin cells, we 
have studied the effect of imipramine and desipramine, on 
depolarization-induced Ca 2 + currents, nicotinic receptor-acti-
vated currents and A T P secretion induced by either choliner-
gic nicotinic agonists or high K + depolarization and the ki-
netics of A T P (co-released with CA during exocytotic 
secretion) release. We have found that both imipramine and 
desipramine inhibited, in a dose-dependent manner, nicotine-
induced and voltage-dependent Ca 2 + currents and this effect 
might explain its inhibitory action on nicotine-induced A T P 
secretion. 
2. Materials and methods 
2.1. Cell isolation and culture 
Bovine chromaffin cells were isolated using collagenase digestion 
and purified through a Percoll gradient as previously described [13]. 
Isolated cells were plated in culture flasks for ATP secretion experi-
ments at a density of 0.5 XlO6 cells/ml. For electrophysiological re-
cordings 10e cells were suspended in 2 ml of culture medium and 
plated in a 35 mm diameter petri dish (Bibby Science Products, Stone, 
England). Cultured cells were kept at 37°C under an atmosphere of 
5% C0 2 . 
2.2. Electrophysiological recording 
2.2.1. Nicotinic receptor currents. Recording of chromaffin cell 
nicotinic receptor-activated currents under voltage-clamp was done, 
using the nystatin-perforated patch-clamp technique, as previously 
described [14]. Chromaffin cells were bathed in a solution with the 
following ionic composition (in mmol/1): NaCl 140; KC1 5.9; MgS04 
1.2; CaCl2 2.5; HEPES 15 and glucose 11 (pH 7.4). The intracellular 
solution had the following composition (in mmol/1): KC1 55; K2S04 
50; MgS04 7; HEPES 10 and nystatin 250 ng/ml (pH 7.2). After 10 
min, nicotine (10 u.M) was applied for 4 s using a fast perfusion 
system under computer control (DAD-12 superfusion system; Adams 
and List, NY). This nicotine pulse was repeated 3 times (Si, S2, S3) at 
15 min intervals. When used, tricyclic antidepressants were present 
5 min before and during S2. 
2.2.2. Voltage-dependent Ca2+ currents. For Ca2+ current record-
ing, the extracellular solution had the following composition (in 
mmol/1): choline Cl 140; KC1 5; CaCl2 2.5; MgCl2 1; HEPES 10 
and glucose 11 (pH 7.4). Since it has been described that choline is 
a partial agonist for cholinergic nicotinic receptors [17] and stimula-
tion of nicotinic receptors by the high doses of choline used in the 
extracellular solution might change [Ca2+],, the cholinergic nicotinic 
blocker D-tubocurarine (10 u.M) was added to the extracellular me-
dium. The ionic composition of the pipette solution was the following 
(in mmol/1): CsCl 55; Cs2S04 50; MgS04 7; HEPES 10 and nystatin 
250 (ig/ml (pH 7.2). A single pulse (Si; 10 s) was applied from a 
holding potential of —55 mV to +5 mV. This pulse protocol was 
repeated, at 10 min intervals (S2, S3). These records were acquired 
at a sampling rate of one point every 5 ms and filtered at 1 kHz. 
Tricyclic antidepressants, when used, were present 5 min before and 
during S2. Time integrals of the current records were used to calculate 
total charge and Ca2+ influx. Voltage pulse protocols and current 
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Fig. 1. Nicotine-induced inward currents in chromaffin cells. A: Inward currents evoked by 3 successive exposures (Si, S2, S3) of one chromaf-
fin cell to nicotine (10 |lM) for 4 s from a holding potential of —55 mV. B: Same as in A, but 5 min before and during S2, desipramine (10 
uM) was present. The experiment was repeated 4 times with similar results. 
transient recordings were under computer control. The linear compo-
nent of the capacity transient was subtracted using a P/4 protocol [18]. 
The non-linear components were digitally subtracted [9]. The open tip 
resistance of the pipettes ranged between 3 and 5 M£2 and were 
covered to near the tip with Sylgard to decrease capacitance. Capacity 
transients were cancelled using the built-in circuitry of the patch-
clamp amplifier (EPC-7, List, Darmstadt, Germany) and the pipette 
potential set at —55 mV. The average capacitance of the cells was 
11.23±0.5 pf and the series resistance (Rs) 12.8±0.92 MW (n= 18). 
No compensation for Rs was used. 
2.3. ATP secretion 
ATP release in response to high K+ or nicotine was determined 
using the luciferin luciferase (L-L) method as previously described 
[19]. Briefly, after 48 to 72 h in culture, cells were mechanically de-
tached from cultured flasks, centrifuged and resuspended at a density 
of 2000 cells/|il. ATP secretion was determined on-line, using the L-L 
method, in a final volume of 200 ul containing 5x 104 cells [19]. This 
low density of cells used in these experiments was required to mini-
mize ATP hydrolysis by ectoATPases [20]. Total ATP content in the 
cell was determined by solubilizing the cells using Extralight (Analyt-
ical Luminescence, San Diego, CA). 
Records of secretory response were filtered with corner frequency 
set at 10 Hz, digitized (Digital Storage Oscilloscope, Nicolet 4094-B, 
Nicolet Texas Instruments Division, Madison, WI) and transferred to 
a computer for kinetic analysis. After normalization, records were 
fitted to the following equation: 
ATP(f) = ^ ( l - exp ( - f / r f ) )
2 + B ( l - e x p ( - f / 4 ) ) (1) 
where A and B represent the steady-state ATP level for each compo-
nent and t[ and tB the time constants for each of the secretion com-
ponents (f, fast; s, slow). Relative amplitude coefficients, A and B, 
were obtained from the fitting procedure and were used to calculate 
the absolute amount of ATP secreted by both fast and slow compo-
nents of secretion. 
2.4. Materials 
Imipramine and desipramine were obtained from Sigma Chemical 
Co., St. Louis, MO; penicillin and streptomycin from Bio-Whittaker 
Bioproducts, Walkersville, MD, and bovine serum albumin from Cal-
biochem, La Jolla, CA. All other reagents were obtained from differ-
ent commercial sources and were of the maximal available purity. 
3. Results 
3.1. Nicotine-induced inward currents 
Nicotme (10 uM) perfusion for 4 s evoked an inward cur-
rent that amounted to —155.1 ± 10.7 p A (« = 42), producing a 
total net charge flux of 314.2 ±26.1 pC (« = 42). When the 
exposure to nicotine was repeated 15 min later, ratio S2/S1 
for peak current was 0.95 ± 0.03 (n = 7) and for charge influx 
was 0.9 ± 0.08 (« = 7). The presence of tricyclic antidepressants 
during S2 produced a marked decrease in both peak current 
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Fig. 2. Effect of tricyclic antidepressants on nicotine-induced peak 
currents (A) and total charge influx (B). The protocol was the same 
as in Fig. IB. Peak current ratios were calculated from current 
records and charge influx ratios from current time integrals. Data 
represent mean±s.e. of 9 controls and 4 experiments for each 
imipramine (•) or desipramine (■) concentration. *P < 0.05 and 
**P<0.01 as compared to data in the absence of tricyclic antide-
pressants. 
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and total charge flux that was reversible upon removal of the 
drug (Fig. 1). The inhibitory effect of imipramine and desi-
pramine was dose-dependent. The blockade reached around 
75% for peak current and 85% for total charge influx at 10 
(iM drug concentration (Fig. 2). 
3.2. ATP secretion and kinetics 
Nicotine (10 uM) evoked the release of 22.2 ± 1.9% of total 
ATP content in the cells («=14; Table 1). Both imipramine 
and desipramine produced a dose-dependent inhibition of 
ATP secretion, being the blockade of ATP secretion complete 
at a concentration of 10 |J,M. 
Kinetic studies have shown that ATP secretion from chro-
maffm cells has two components: one fast, that might repre-
sent secretion from docked vesicles and the other slow, ac-
counting for refilling of docking sites by vesicles located inside 
the cell and its further secretion [21]. We have studied whether 
the blocking action of tricyclic antidepressants on nicotine-
induced ATP secretion takes place on the fast or the slow 
component of secretion. As it can be observed in Fig. 3, 
both components of ATP secretion are affected in a dose-
dependent manner by imipramine and desipramine, being 
more important the inhibitory action on the slow component 
of secretion (Fig. 3B). However, time constant for the fast 
component of ATP secretion was not affected by the presence 
of tricyclic antidepressants, although the time constant for the 
slow component of secretion was markedly decreased by both 
imipramine and desipramine (data not shown). 
3.3. Effect of imipramine and desipramine on voltage-dependent 
Ca2+ currents 
Depolarization of chromaffm cells from a holding potential 
of —55 mV to 5 mV for 10 s induced an inward current of 
—193.9± 13.6 pA and the influx of 1.36±0.11 fmoles of Ca2+ 
(n - 15). This current inactivated with a x of 1.20 ± 0.09 s (Fig. 
4A). A second, identical, depolarization (S2) repeated 10 min 
later did not modify significantly Ca2+ entry (data not 
shown), being ratio S2/S! for peak current 0.95 ± 0.03. When 
imipramine (10 uM) was present 5 min before and during S2 a 
marked decrease in peak current (ratio S2/S1 of 0.7 ± 0.07, 
w = 4; Fig. 4B) could be observed. A similar effect was ob-
served for desipramine (10 u,M) (Fig. 4B), being the ratio S2/ 
Si for peak current 0.79 ±0.05 (« = 4). 
3.4. Effect of tricyclic antidepressant on depolarization-induced 
ATP secretion 
Exposure of chromaffm cells to high K+ (75 mM) evoked 
the secretion of about 17.3 ± 1.1% of total ATP content in the 
cells. Imipramine produced a partial blockade (about 40%) of 
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Fig. 3. Effect of imipramine (•) and desipramine (■) on nicotine-in-
duced fast (A) and slow (B) components of ATP secretion. Data 
were calculated as stated in Section 2 and represent meants.e. of 
20 experiments in the absence of antidepressant drugs and from 7 
to 11 in the presence of either imipramine or desipramine. *P < 0.05 
and **P < 0.01 as compared to data in the absence of tricyclic anti-
depressants. 
high K+-induced ATP secretion at a concentration of 10 |J.M 
(Table 1). A similar action could be observed in the presence 
of desipramine (Table 1). 
4. Discussion 
The results presented here show that the tricyclic antide-
pressant drugs, imipramine and desipramine, potently block 
nicotine-induced ATP secretion from bovine chromaffin cells 
and that this effect might be explained by the potent and 
reversible blockade that these drugs produce on nicotine-in-
duced currents in chromaffin cells. The blocking effect of ei-
Table 1 
Effect of tricyclic antidepressants on nicotine (10 liM) and high K+ ■(75 mM)-induced ATP secretion 
Tricyclic antidepressant Nicotine (10 uM) K+ (75 mM) 
None 
Imipramine 10 nM 
Imipramine 100 nM 
Imipramine 1 uM 
Desipramine 10 nM 
Desipramine 100 nM 
Desipramine 1 uM 
22.22±1.90(n = 22) 
13.79 ± 0.52 (rc = 9)* 
11.96 ±0.66 (« = 8)* 
3.82 ±0.65 (n = 8)* 
20.08± 1.12 (« = 5) 
14.64 ± 1.96 (rc = 6)* 
9.35 ±1.83 (n = 9)* 
17.30 ± 1.06 (n = 20) 
14.85 ± 0.35 (n = 7) 
14.82 ±1.21 («=11) 
10.50 ± 1.06 (« = 9)* 
14.50 ± 0.49 (« = 7)* 
12.54 ± 1.46 (n = 8)* 
9.47 ±1.25 (« = 9)* 
Secretion is expressed as fractional ATP secretion. Data represent mean ± standard error of the number of experiments indicated in parenthesis. 
*P < 0.05 as compared with control in absence of tricyclic antidepressants. 
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Fig. 4. Depolarization-induced Ca2+ currents in chromaffin cells. A: 
Inward Ca2+ currents induced in chromaffin cells by 3 consecutive 
depolarizing pulses (Si, S2, S3) from a holding potential of —55 mV 
to 5 mV for 10 s applied 10 min apart. Five min before and during 
the second pulse imipramine (10 uM) or desipramine (10 |iM) were 
present in the bath. B: Effect of imipramine (10 (J.M) or desipramine 
(10 |iM) on peak Ca2+ currents. The protocol used was the same as 
in A. Data represent mean ± s.e. of 4 experiments. 
ther imipramine or desipramine on high K+-induced depola-
rization is less pronounced. However, certain degree of block-
ade of voltage-dependent Ca2+ currents can be observed, sug-
gesting that a secondary target for the blocking actions of 
these drugs on nicotine-induced ATP secretion might be volt-
age-dependent Ca2+ channels. 
The main finding of this work is that tricyclic antidepres-
sants block much more efficiently nicotine-induced than high 
K+-induced ATP secretion. This effect might be explained by 
the blockade, by tricyclic antidepressants, of nicotine-acti-
vated receptor currents measured using the nystatin-perfo-
rated patch-clamp technique. This data might explain pre-
vious results that showed that imipramine was much more 
potent to block nicotine-induced than high K+-induced 
[3H]norepinephrine (3H-NA) secretion from chromaffin cells 
[16]. On the other side, it has been described that, in chro-
maffin cells, nicotine-induced currents through activation of 
cholinergic nicotinic receptors are blocked by a variety of 
drugs and toxins [12-15]. Taken together, these data indicate 
that the neuronal cholinergic nicotinic receptor might be a 
target through which different drugs and toxins might modu-
late the secretory activity of bovine chromaffin cells. 
Tricyclic antidepressants also partially blocked depolariza-
tion-induced ATP secretion, suggesting that, besides the ac-
tions on neuronal nicotinic receptors, an effect on voltage-
dependent Ca2+ channels might take place. High concentra-
tions (10 uM) of either imipramine or desipramine produced a 
similar degree of blockade (about 40%) of peak current in 
response to long depolarizing pulses and of high K+-induced 
ATP secretion. This would suggest that a secondary target for 
the blocking effects of tricyclic antidepressant on ATP secre-
tion might be voltage-dependent Ca2+ channels. These data 
would agree with a previous report showing that both imi-
pramine and desipramine partially blocked 45Ca2+ uptake in 
response to high K+ in rat brain cortex synaptosomes [22]. 
In summary, the data presented here suggest that tricyclic 
antidepressants block nicotine-induced CA and ATP secretion 
by acting on two targets: one is the nicotinic receptor itself 
and the second one is voltage-dependent Ca2+ channels. 
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